Try a new search

Format these results:

Searched for:

in-biosketch:true

person:parkc07

Total Results:

124


CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia

Hosen, Naoki; Park, Christopher Y; Tatsumi, Naoya; Oji, Yusuke; Sugiyama, Haruo; Gramatzki, Martin; Krensky, Alan M; Weissman, Irving L
Permanent cure of acute myeloid leukemia (AML) by chemotherapy alone remains elusive for most patients because of the inability to effectively eradicate leukemic stem cells (LSCs), the self-renewing component of the leukemia. To develop therapies that effectively target LSC, one potential strategy is to identify cell surface markers that can distinguish LSC from normal hematopoietic stem cells (HSCs). In this study, we employ a signal sequence trap strategy to isolate cell surface molecules expressed on human AML-LSC and find that CD96, which is a member of the Ig gene superfamily, is a promising candidate as an LSC-specific antigen. FACS analysis demonstrates that CD96 is expressed on the majority of CD34(+)CD38(-) AML cells in many cases (74.0 +/- 25.3% in 19 of 29 cases), whereas only a few (4.9 +/- 1.6%) cells in the normal HSC-enriched population (Lin(-)CD34(+)CD38(-)CD90(+)) expressed CD96 weakly. To examine whether CD96(+) AML cells are enriched for LSC activity, we separated AML cells into CD96(+) and CD96(-) fractions and transplanted them into irradiated newborn Rag2(-/-) gamma(c)(-/-) mice. In four of five samples, only CD96(+) cells showed significant levels of engraftment in bone marrow of the recipient mice. These results demonstrate that CD96 is a cell surface marker present on many AML-LSC and may serve as an LSC-specific therapeutic target.
PMCID:1904175
PMID: 17576927
ISSN: 1091-6490
CID: 2119902

MicroRNA profiling of human acute myeloid leukemia and normal hematopoietic stem/progenifor cells reveals a leukemia stem cell signature [Meeting Abstract]

Park, Christopher Y; Wang, Yulei; Prohaska, Susan; Tseng, Diane; Weissman, Irving L
ISI:000251100801048
ISSN: 0006-4971
CID: 2119922

The cancer stem cell hypothesis: a work in progress

Tan, Brenton Thomas; Park, Christopher Yongchul; Ailles, Laurie Elizabeth; Weissman, Irving L
There is a growing body of evidence that supports the idea that malignant tumors are initiated and maintained by a population of tumor cells that share similar biologic properties to normal adult stem cells. This model, the cancer stem cell (CSC) hypothesis, is based on the observation that tumors, like adult tissues, arise from cells that exhibit the ability to self-renew as well as give rise to differentiated tissue cells. Although the concept of the CSC is not entirely new, advances made over the past two decades in our understanding of normal stem cell biology in conjunction with the recent application of these concepts to experimentally define CSCs have resulted in the identification of CSCs in several human malignancies.
PMID: 17075578
ISSN: 0023-6837
CID: 2120082

Development of a novel xenotransplantation system for studying human acute myeloid leukemia. [Meeting Abstract]

Park, Christopher Y; Majeti, Ravindra; Tan, Brenton T; Weissman, Irving L
ISI:000242440002465
ISSN: 0006-4971
CID: 2119912